When working with Anastrozole, a selective aromatase inhibitor used primarily to treat hormone‑receptor‑positive breast cancer in post‑menopausal women. Also known as Arimidex, it blocks the enzyme aromatase, which converts androgens into estrogen. This reduction in estrogen helps slow or stop the growth of cancers that rely on the hormone for fuel. Aromatase inhibitor, a class of drugs that lower estrogen levels by inhibiting the aromatase enzyme is the broader group Anastrozole belongs to, and it works hand‑in‑hand with breast cancer, a disease where cells in the breast grow out of control, often driven by estrogen in certain subtypes. The drug’s primary goal is to create a hormonal environment where estrogen‑dependent tumors struggle to survive. In practice, doctors prescribe it after surgery, during radiation, or alongside other hormone therapies to keep the cancer from returning. This link—Anastrozole reduces estrogen, estrogen fuels some breast cancers—forms a clear cause‑effect chain that guides treatment decisions worldwide.
A clear side‑by‑side look at Altraz (Anastrozole) and its main alternatives, covering how they work, effectiveness, side effects, costs and how to choose the right option for postmenopausal breast‑cancer patients.
More